We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation
Cara Dolin, MD
Jennifer Simpson
Diana Girnita, MD ,PhD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
What’s New About Gout? Rheumatology Perspective
Richard Johnson, MD
John K. Botson, MD, RPh
Gout Beyond the Joints: What’s the Hidden Danger?
Can You Manage Patients With Uncontrolled Gout More Effectively?
Abdul Abdellatif, MD, FASN
Center of the Target: Which Patients Are Most Likely to Develop Gout?
What’s New About Gout? Nephrology Perspective
Is Managing Gout in the Nephrology Clinic a Challenge?
Is Gout Hiding in the Nephrology Clinic?
Should We Look for Gout in the Cardiology Clinic?
Brittany Weber, MD, PhD
Treat or Refer: Who Is Responsible for Managing Gout?
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
What Are the Emerging Therapies for Managing Gout?
Can We Do Better in IgAN?
Jonathan Barratt, PhD
Annette Bruchfeld, MD, PhD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education